Yakkanti Ramakanth R, Mohile Neil V, Cohen-Levy Wayne B, Haziza Sagie, Lavelle Matthew J, Bellam Krishna G, Quinnan Stephen M
Department of Orthopaedic Surgery, University of Miami University Hospital, West Wing, 1321 NW 14th st, Suite 306, Miami, FL, 33125, USA.
University Hospital/Case Western Reserve University, Cleveland, OH, USA.
Arch Orthop Trauma Surg. 2023 Mar;143(3):1311-1321. doi: 10.1007/s00402-021-04278-0. Epub 2021 Dec 2.
The American Academy of Orthopaedic Surgeons does not currently provide clinical practice guidelines for management of PAF. Accordingly, this article aims to review and consolidate the relevant historical and recent literature in important topics pertaining to perioperative management of PAF.
A thorough literature review using PubMed, Cochrane and Embase databases was performed to assess preoperative, intraoperative and postoperative management of PAF fracture. Topics reviewed included: time from injury to definitive fixation, the role of inferior vena cava filters (IVCF), tranexamic acid (TXA) use, intraopoperative cell salvage, incisional negative pressure wound therapy (NPWT), intraoperative antibiotic powder use, heterotopic ossification prophylaxis, and pre- and postoperative venous thromboembolism (VTE) prophylaxis.
A total of 126 articles pertaining to the preoperative, intraoperative and postoperative management of PAF were reviewed. Articles reviewed by topic include 13 articles pertaining to time to fixation, 23 on IVCF use, 14 on VTE prophylaxis, 20 on TXA use, 10 on cell salvage, 10 on iNPWT 14 on intraoperative antibiotic powder and 20 on HO prophylaxis. An additional eight articles were reviewed to describe background information. Five articles provided information for two or more treatment modalities and were therefore included in multiple categories when tabulating the number of articles reviewed per topic.
The literature supports the use of radiation therapy for HO prophylaxis, early (< 5 days from injury) surgical intervention and the routine use of intraoperative TXA. The literature does not support the routine use of iNPWT or IVCF. There is inadequate information to make a recommendation regarding the use of cell salvage and wound infiltration with antibiotic powder. While the routine use of chemical VTE prophylaxis is recommended, there is insufficient evidence to recommend the optimal agent and duration of therapy.
美国矫形外科医师学会目前未提供关于骨盆髋臼骨折(PAF)管理的临床实践指南。因此,本文旨在回顾和整合与PAF围手术期管理重要主题相关的历史和近期文献。
使用PubMed、Cochrane和Embase数据库进行全面的文献综述,以评估PAF骨折的术前、术中和术后管理。回顾的主题包括:从受伤到确定性固定的时间、下腔静脉滤器(IVCF)的作用、氨甲环酸(TXA)的使用、术中细胞回收、切口负压伤口治疗(NPWT)、术中抗生素粉末的使用、异位骨化预防以及术前和术后静脉血栓栓塞(VTE)预防。
共回顾了126篇关于PAF术前、术中和术后管理的文章。按主题回顾的文章包括13篇关于固定时间的文章、23篇关于IVCF使用的文章、14篇关于VTE预防的文章、20篇关于TXA使用的文章、10篇关于细胞回收的文章、10篇关于iNPWT的文章、14篇关于术中抗生素粉末的文章和20篇关于HO预防的文章。另外还回顾了8篇文章以描述背景信息。5篇文章提供了两种或更多治疗方式的信息,因此在统计每个主题回顾的文章数量时被纳入多个类别。
文献支持使用放射治疗预防HO、早期(受伤后<5天)手术干预以及术中常规使用TXA。文献不支持常规使用iNPWT或IVCF。关于使用细胞回收和抗生素粉末伤口浸润,没有足够的信息来提出建议。虽然建议常规使用化学VTE预防,但没有足够的证据推荐最佳药物和治疗持续时间。